Login / Signup

Lipocalin-2 as a prognostic biomarker and its association with systemic inflammation in small cell lung cancer.

Se-Il GoJung Wook YangWoo Je LeeEun Jeong JeongSungwoo ParkGyeong-Won Lee
Published in: Thoracic cancer (2024)
High lipocalin-2 expression is potentially associated with poorer survival in LD-SCLC. Combining lipocalin-2 with other inflammation-related markers could improve prognostic stratification.
Keyphrases
  • small cell lung cancer
  • poor prognosis
  • oxidative stress
  • free survival
  • long non coding rna